Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Psychiatric Research Study For Cancer Patients
The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center is conducting a
study designed to measure the effectiveness of the novel psychoactive medication psilocybin
on the reduction of anxiety, depression, and physical pain.
Phase:
Phase 1
Details
Lead Sponsor:
Los Angeles Biomedical Research Institute Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center